204 related articles for article (PubMed ID: 25162816)
1. Field study of adult male circumcision using the ShangRing in routine clinical settings in Kenya and Zambia.
Sokal DC; Li PS; Zulu R; Awori QD; Agot K; Simba RO; Combes S; Lee RK; Hart C; Lai JJ; Zyambo Z; Goldstein M; Feldblum PJ; Barone MA
J Acquir Immune Defic Syndr; 2014 Dec; 67(4):430-7. PubMed ID: 25162816
[TBL] [Abstract][Full Text] [Related]
2. Rollout of ShangRing circumcision with active surveillance for adverse events and monitoring for uptake in Kenya.
Odoyo-June E; Owuor N; Kassim S; Davis S; Agot K; Serrem K; Otieno G; Awori Q; Hines J; Toledo C; Laube C; Kisia C; Aoko A; Ojiambo V; Mwandi Z; Juma A; Kigen B
PLoS One; 2019; 14(9):e0222942. PubMed ID: 31557208
[TBL] [Abstract][Full Text] [Related]
3. Longer-Term Follow-Up of Kenyan Men Circumcised Using the ShangRing Device.
Feldblum PJ; Okech J; Ochieng R; Hart C; Kiyuka G; Lai JJ; Veena V
PLoS One; 2015; 10(9):e0137510. PubMed ID: 26367141
[TBL] [Abstract][Full Text] [Related]
4. Use of the ShangRing circumcision device in boys below 18 years old in Kenya: results from a pilot study.
Awori QD; Lee RK; Li PS; Moguche JN; Ouma D; Sambai B; Goldstein M; Barone MA
J Int AIDS Soc; 2017 Jul; 20(1):21588. PubMed ID: 28715157
[TBL] [Abstract][Full Text] [Related]
5. Prospective Observational Study of the ShangRing Device for Adult Medical Male Circumcision in a Routine Clinical Setting in Malawi.
Feldblum PJ; Mwambula C; Selemani M; Long S; Telela DJ; Mwenyekonde E; Lai JJ; Veena V; Mbeya P
Afr J Reprod Health; 2016 Dec; 20(4):60-66. PubMed ID: 29566320
[TBL] [Abstract][Full Text] [Related]
6. Randomized Controlled Trial of the ShangRing for Adult Medical Male Circumcision: Safety, Effectiveness, and Acceptability of Using 7 Versus 14 Device Sizes.
Feldblum PJ; Zulu R; Linyama D; Long S; Nonde TJ; Lai JJ; Kashitala J; Veena V; Kasonde P
J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S30-5. PubMed ID: 27331587
[TBL] [Abstract][Full Text] [Related]
7. Surgical Outcomes of Newly Trained ShangRing Circumcision Providers.
Awori QD; Lee RK; Li PS; Zulu R; Agot K; Combes S; Simba RO; Hart C; Lai JJ; Zyambo Z; Goldstein M; Feldblum PJ; Barone MA
J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S13-7. PubMed ID: 27331584
[TBL] [Abstract][Full Text] [Related]
8. Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial.
Awori Q; Li PS; Lee RK; Ouma D; Oundo M; Barasa M; Obura N; Mwamkita D; Simba R; Oketch J; Nyangweso N; Maina M; Kiswi N; Kirui M; Chirchir B; Goldstein M; Barone MA
PLoS One; 2019; 14(8):e0218066. PubMed ID: 31412032
[TBL] [Abstract][Full Text] [Related]
9. Simplifying the ShangRing technique for circumcision in boys and men: use of the no-flip technique with randomization to removal at 7 days versus spontaneous detachment.
Barone MA; Li PS; Lee RK; Ouma D; Oundo M; Barasa M; Oketch J; Otiende P; Nyangweso N; Maina M; Kiswi N; Chirchir B; Goldstein M; Awori QD
Asian J Androl; 2019; 21(4):324-331. PubMed ID: 30520424
[TBL] [Abstract][Full Text] [Related]
10. Safety, effectiveness and acceptability of the PrePex device for adult male circumcision in Kenya.
Feldblum PJ; Odoyo-June E; Obiero W; Bailey RC; Combes S; Hart C; Jou Lai J; Fischer S; Cherutich P
PLoS One; 2014; 9(5):e95357. PubMed ID: 24788898
[TBL] [Abstract][Full Text] [Related]
11. Men's Understanding of and Experiences During the Postcircumcision Abstinence Period: Results From a Field Study of ShangRing Circumcision During Routine Clinical Services in Kenya and Zambia.
Barone MA; Li PS; Zulu R; Awori QD; Agot K; Combes S; Simba RO; Lee RK; Hart C; Lai JJ; Zyambo Z; Goldstein M; Feldblum PJ; Sokal DC
J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S18-23. PubMed ID: 27331585
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial of the shang ring versus conventional surgical techniques for adult male circumcision: safety and acceptability.
Sokal DC; Li PS; Zulu R; Awori QD; Combes SL; Simba RO; Lee R; Hart C; Perchal P; Hawry HJ; Bowa K; Goldstein M; Barone MA
J Acquir Immune Defic Syndr; 2014 Apr; 65(4):447-55. PubMed ID: 24583615
[TBL] [Abstract][Full Text] [Related]
13. No-flip ShangRing circumcision in 10-12 year old boys: Results from randomized clinical trials in Kenya.
Al Hussein Alawamlh O; Awori QD; Barone MA; Kim SJ; Goldstein M; Li PS; Lee RK
PLoS One; 2020; 15(5):e0233150. PubMed ID: 32442198
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of the Shang Ring for adult male circumcision with removal at one to three weeks: delayed removal leads to detachment.
Barone MA; Awori QD; Li PS; Simba RO; Weaver MA; Okech JO; Aduda AO; Cherutich P; Muraguri N; Wekesa JM; Nyanchoka J; Perchal P; Masson P; Lee R; Goldstein M; Kioko J; Lusi O; Sokal DC
J Acquir Immune Defic Syndr; 2012 Jul; 60(3):e82-9. PubMed ID: 22343180
[TBL] [Abstract][Full Text] [Related]
15. Timing of adverse events among voluntary medical male circumcision clients: Implications from routine service delivery in Zimbabwe.
Feldacker C; Bochner AF; Murenje V; Makunike-Chikwinya B; Holec M; Xaba S; Balachandra S; Mandisarisa J; Sidile-Chitimbire V; Barnhart S; Tshimanga M
PLoS One; 2018; 13(9):e0203292. PubMed ID: 30192816
[TBL] [Abstract][Full Text] [Related]
16. Safety of adult medical male circumcision performed by non-physician clinicians in Kenya: a prospective cohort study.
Frajzyngier V; Odingo G; Barone M; Perchal P; Pavin M
Glob Health Sci Pract; 2014 Feb; 2(1):93-102. PubMed ID: 25276565
[TBL] [Abstract][Full Text] [Related]
17. ShangRing versus Mogen clamp for early infant male circumcision in eastern sub-Saharan Africa: a multicentre, non-inferiority, adaptive, randomised controlled trial.
Basourakos SP; Nang QG; Ballman KV; Al Awamlh OAH; Punjani N; Ho K; Barone MA; Awori QD; Ouma D; Oketch J; Christensen AE; Hellar A; Makokha M; Isangu A; Salim R; Lija J; Gray RH; Kiboneka S; Anok A; Kigozi G; Nakabuye R; Ddamulira C; Mulooki A; Odiya S; Nazziwa R; Goldstein M; Li PS; Lee RK
Lancet Glob Health; 2022 Oct; 10(10):e1514-e1522. PubMed ID: 36113534
[TBL] [Abstract][Full Text] [Related]
18. Is the PrePex device an alternative for surgical male circumcision in adolescents ages 13-17 years? Findings from routine service delivery during active surveillance in Zimbabwe.
Mavhu W; Hatzold K; Madidi N; Maponga B; Dhlamini R; Munjoma M; Xaba S; Ncube G; Mugurungi O; Cowan FM
PLoS One; 2019; 14(3):e0213399. PubMed ID: 30856228
[TBL] [Abstract][Full Text] [Related]
19. One-arm, open-label, prospective, cohort field study to assess the safety and efficacy of the PrePex device for scale-up of nonsurgical circumcision when performed by nurses in resource-limited settings for HIV prevention.
Mutabazi V; Kaplan SA; Rwamasirabo E; Bitega JP; Ngeruka ML; Savio D; Karema C; Binagwaho A
J Acquir Immune Defic Syndr; 2013 Jul; 63(3):315-22. PubMed ID: 23466648
[TBL] [Abstract][Full Text] [Related]
20. Time to complete wound healing in HIV-positive and HIV-negative men following medical male circumcision in Kisumu, Kenya: a prospective cohort study.
Rogers JH; Odoyo-June E; Jaoko W; Bailey RC
PLoS One; 2013; 8(4):e61725. PubMed ID: 23613918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
